Immunology
Summary
Lesson Outline
Don't stop here!
Get access to 22 more Immunology lessons & 13 more medical school learning courses with one subscription!
FAQs
Somatic hypermutation plays a critical role in the immune response by introducing point mutations into the variable regions of an antibody gene in B cells. This process, which typically occurs within germinal centers in secondary lymphoid organs, results in a diverse pool of antibodies. Some of these mutations may enhance the binding affinity of the B cell receptor (BCR) for a specific antigen, leading to a more effective immune response.
Affinity maturation, a process that occurs following somatic hypermutation, is crucial to the immune defense mechanism. It's the process by which B cells that produce high-affinity antibodies are selected within germinal centers. In other words, B cells with BCRs that bind most strongly to an antigen undergo clonal expansion, hence producing more of their kind. Over time, this leads to a predominance of high-affinity antibodies, strengthening the immune response.
Activation-induced cytidine deaminase is an enzyme that plays a crucial role in instigating somatic hypermutation. AID triggers the mutation process by converting cytidine to uracil in DNA, which subsequently leads to point mutations during DNA replication. These modifications in the DNA sequence ultimately generate the diversity necessary for the production of high-affinity antibodies.
Following antigen binding and selection through somatic hypermutation and affinity maturation, activated B cells proliferate in a process called clonal expansion. This process generates two types of cells: plasma cells and memory B cells. Plasma cells are responsible for producing and releasing high-affinity antibodies into the bloodstream to neutralize the specific antigen immediately. On the other hand, memory B cells persist in the body and mediate the faster and larger immune response upon re-exposure to the same antigen, contributing to long-lasting immunity.
Isotype class switching is a process that occurs during B cell differentiation allowing the resulting plasma cell to produce an antibody isotype other than IgM or IgD. The choice of isotypeÑIgG, IgA, or IgEÑdepends on the specific needs of the immune response. Each of these isotypes has unique properties, making them more suitable for fighting different types of antigens or infections. For instance, IgG antibodies are highly versatile and can cross the placenta, providing passive immunity to the fetus. AID also plays a vital role in mediating isotype class switching.